Evidence map›Paper›PMID 36281924›Full record

ReviewMolecular medicine reports2022

Role of glucose metabolism in ocular angiogenesis (Review).

Qing Li, Xiao Gui, Haorui Zhang, Weiye Zhu, Rui Zhang, Wei Shen, Hongyuan Song

Abstract readReview
In one paragraph

Review in Molecular medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Research progress on the relationship between Nesfatin-1 and glucose metabolism.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qing Li *Department of Ophthalmology, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Xiao Gui *Department of Ophthalmology, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Haorui ZhangDepartment of Ophthalmology, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Weiye ZhuDepartment of Ophthalmology, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Rui ZhangDepartment of Ophthalmology, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Wei ShenDepartment of Ophthalmology, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Hongyuan SongDepartment of Ophthalmology, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucose metabolism, the major source of energy, plays a crucial role in physiological cell function and the maintenance of homeostasis. Glucose acts as the predominant source of metabolic fuel in the generation of ATP and is involved in biosynthesis and epigenetics. Thus, glucose metabolism maintains a key role in cell function, homeostasis, energy generation, biosynthesis and epigenetics. An increasing number of studies have revealed that glucose metabolism is intricately involved in angiogenesis, with the disruption of angiogenesis contributing to several vascular diseases. Ocular vascular diseases are common ophthalmological disorders, and the prevalence of these disorders is increasing annually. Ocular vascular diseases largely occur from abnormal congenital development or acquired disturbances to the vasculature. Thus, identifying the process of occurrence and development of physiological and pathological angiogenesis is of utmost importance, and this involves understanding the inseparable role of intercellular communications between vascular cells. Although vascular endothelial growth factor (VEGF) is a well‑recognized therapeutic target for the management of ocular vascular diseases, VEGF‑based therapy fails to achieve the desired therapeutic effects in several cases, partly due to drug resistance and non‑compliance. In the present review, current knowledge on the processes and roles of glucose metabolism in governing both physiological and pathological ocular angiogenesis are summarized, highlighting vascular glucose metabolism as a promising strategy for maintaining or restoring the physiological functions of the vasculature, thus potentially ameliorating ocular vascular diseases.

Indexed as

Vascular DiseasesVascular Endothelial Growth Factor AAdenosine TriphosphateAngiogenesis InhibitorsGlucoseHumansNeovascularization, PathologicVascular Endothelial Growth FactorsAdenosine TriphosphateAngiogenesis InhibitorsGlucoseVascular Endothelial Growth Factor AVascular Endothelial Growth Factorsendothelial cellsglucose metabolismglycolysisocular angiogenesisvascular

Identifiers

PMID36281924
PMCPMC9641713

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.